These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 34642255)
1. SARS-CoV-2 antibodies in Ontario health care workers during and after the first wave of the pandemic: a cohort study. Science M; Bolotin S; Silverman M; Nadarajah J; Maguire B; Parekh RS; McGeer A; Schwartz KL; Alexander L; Allen U; Ariyarajah A; Castellani L; Cohn RD; Downing M; Katz K; Kazmi K; Leis JA; Liu D; Pernica JM; Schneiderman JE; Sumaida M; Campigotto A CMAJ Open; 2021; 9(4):E929-E939. PubMed ID: 34642255 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile. Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287 [TBL] [Abstract][Full Text] [Related]
3. Prevalence, Persistence, and Factors Associated with SARS-CoV-2 IgG Seropositivity in a Large Cohort of Healthcare Workers in a Tertiary Care University Hospital in Northern Italy. Scozzari G; Costa C; Migliore E; Coggiola M; Ciccone G; Savio L; Scarmozzino A; Pira E; Cassoni P; Galassi C; Cavallo R; The Collaborative Group Viruses; 2021 Jun; 13(6):. PubMed ID: 34205134 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland. Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673 [TBL] [Abstract][Full Text] [Related]
5. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study. Iversen K; Bundgaard H; Hasselbalch RB; Kristensen JH; Nielsen PB; Pries-Heje M; Knudsen AD; Christensen CE; Fogh K; Norsk JB; Andersen O; Fischer TK; Jensen CAJ; Larsen M; Torp-Pedersen C; Rungby J; Ditlev SB; Hageman I; Møgelvang R; Hother CE; Gybel-Brask M; Sørensen E; Harritshøj L; Folke F; Sten C; Benfield T; Nielsen SD; Ullum H Lancet Infect Dis; 2020 Dec; 20(12):1401-1408. PubMed ID: 32758438 [TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study. Brehm TT; Schwinge D; Lampalzer S; Schlicker V; Küchen J; Thompson M; Ullrich F; Huber S; Schmiedel S; Addo MM; Lütgehetmann M; Knobloch JK; Schulze Zur Wiesch J; Lohse AW Int J Hyg Environ Health; 2021 Mar; 232():113671. PubMed ID: 33338782 [TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts. Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India. Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study. Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ; J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workers. Morris CR; Sullivan P; Mantus G; Sanchez T; Zlotorzynska M; Hanberry B; Iyer S; Heilman S; Camacho-Gonzalez A; Figueroa J; Manoranjithan S; Leake D; Mendis R; Cleeton R; Chen C; Krieger R; Bush P; Hughes T; Little WK; Suthar MS; Wrammert J; Vos MB Int J Infect Dis; 2021 Apr; 105():474-481. PubMed ID: 33722686 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada. Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398 [TBL] [Abstract][Full Text] [Related]
12. COVID-19: Hotspot hospital?- seroprevalence of SARS-CoV-2 antibodies in hospital employees in a secondary care hospital network in Germany: Intermediate results of a prospective surveillance study. Hildebrandt A; Hökelekli O; Uflacker L; Rudolf H; Gatermann SG Int J Hyg Environ Health; 2021 Jun; 235():113771. PubMed ID: 34049092 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of SARS-CoV-2 IgG/IgM Antibodies among Danish and Swedish Falck Emergency and Non-Emergency Healthcare Workers. Laursen J; Petersen J; Didriksen M; Iversen K; Ullum H Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33494409 [TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala. Davila-Siliezar P; Wer A; Barnoya J Ann Med; 2021 Dec; 53(1):1956-1959. PubMed ID: 34727801 [TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust. Grant JJ; Wilmore SMS; McCann NS; Donnelly O; Lai RWL; Kinsella MJ; Rochford HL; Patel T; Kelsey MC; Andrews JA Infect Control Hosp Epidemiol; 2021 Feb; 42(2):212-214. PubMed ID: 32746953 [TBL] [Abstract][Full Text] [Related]
16. Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests. van Dam P; Huizing M; Roelant E; Hotterbeekx A; De Winter FHR; Kumar-Singh S; Moons P; Amajoud Z; Vulsteke C; Croes L; Janssens A; Berneman Z; Prenen H; Meuris L; Vanden Berghe W; Smits E; Peeters M Eur J Cancer; 2021 May; 148():328-339. PubMed ID: 33773276 [TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis. Galanis P; Vraka I; Fragkou D; Bilali A; Kaitelidou D J Hosp Infect; 2021 Feb; 108():120-134. PubMed ID: 33212126 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Shields A; Faustini SE; Perez-Toledo M; Jossi S; Aldera E; Allen JD; Al-Taei S; Backhouse C; Bosworth A; Dunbar LA; Ebanks D; Emmanuel B; Garvey M; Gray J; Kidd IM; McGinnell G; McLoughlin DE; Morley G; O'Neill J; Papakonstantinou D; Pickles O; Poxon C; Richter M; Walker EM; Wanigasooriya K; Watanabe Y; Whalley C; Zielinska AE; Crispin M; Wraith DC; Beggs AD; Cunningham AF; Drayson MT; Richter AG Thorax; 2020 Dec; 75(12):1089-1094. PubMed ID: 32917840 [TBL] [Abstract][Full Text] [Related]
19. Disparities in Seroprevalence of SARS-CoV-2 Immunoglobulin Antibodies in a Large Midwestern Health Care System. Fitzpatrick V; Rivelli A; Blair C; Copeland K; Richards J Public Health Rep; 2021 May; 136(3):361-367. PubMed ID: 33673779 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran. Mortezagholi S; Rostamzadeh D; Alinejad M; Younesi V; Tabarsi P; Shabani M Iran J Immunol; 2021 Mar; 18(1):82-92. PubMed ID: 33787517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]